Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Cell Death Dis ; 3: e282, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22419111

ABSTRACT

The Trans-activator protein (Tat) of human immunodeficiency virus (HIV) is a pleiotropic protein involved in different aspects of AIDS pathogenesis. As a number of viral proteins Tat is suspected to disturb mitochondrial function. We prepared pure synthetic full-length Tat by native chemical ligation (NCL), and Tat peptides, to evaluate their direct effects on isolated mitochondria. Submicromolar doses of synthetic Tat cause a rapid dissipation of the mitochondrial transmembrane potential (ΔΨ(m)) as well as cytochrome c release in mitochondria isolated from mouse liver, heart, and brain. Accordingly, Tat decreases substrate oxidation by mitochondria isolated from these tissues, with oxygen uptake being initially restored by adding cytochrome c. The anion-channel inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) protects isolated mitochondria against Tat-induced mitochondrial membrane permeabilization (MMP), whereas ruthenium red, a ryanodine receptor blocker, does not. Pharmacologic inhibitors of the permeability transition pore, Bax/Bak inhibitors, and recombinant Bcl-2 and Bcl-XL proteins do not reduce Tat-induced MMP. We finally observed that Tat inhibits cytochrome c oxidase (COX) activity in disrupted mitochondria isolated from liver, heart, and brain of both mouse and human samples, making it the first described viral protein to be a potential COX inhibitor.


Subject(s)
Electron Transport Complex IV/antagonists & inhibitors , Mitochondria/drug effects , tat Gene Products, Human Immunodeficiency Virus/pharmacology , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Animals , Brain/drug effects , Brain/enzymology , Cytochromes c/metabolism , Electron Transport Complex IV/metabolism , Humans , Ion Transport , Liver/drug effects , Liver/enzymology , Membrane Potential, Mitochondrial , Mice , Mice, Inbred BALB C , Mitochondria/enzymology , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/metabolism , Myocardium/enzymology , Oxidative Phosphorylation , Permeability , Proto-Oncogene Proteins c-bcl-2/metabolism , tat Gene Products, Human Immunodeficiency Virus/chemistry , tat Gene Products, Human Immunodeficiency Virus/physiology
2.
Cell Death Differ ; 14(3): 422-35, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16888644

ABSTRACT

The HIV-1 encoded apoptogenic protein Vpr induces mitochondrial membrane permeabilization (MMP) via interactions with the voltage-dependent anion channel (VDAC) and the adenine nucleotide translocator (ANT). We have designed a peptide, TEAM-VP, composed of two functional domains, one a tumor blood vessel RGD-like 'homing' motif and the other an MMP-inducing sequence derived from Vpr. When added to isolated mitochondria, TEAM-VP interacts with ANT and VDAC, reduces oxygen consumption and overcomes Bcl-2 protection to cause inner and outer MMP. TEAM-VP specifically recognizes cell-surface expressed alpha(V)beta(3) integrins, internalizes, temporarily localizes to lysosomes and progressively co-distributes with the mitochondrial compartment with no sign of lysosomal membrane permeabilization. Finally TEAM-VP reaches mitochondria of angiogenic endothelial cells to induce mitochondrial fission, dissipation of the mitochondrial transmembrane potential (DeltaPsi(m)), cytochrome c release and apoptosis hallmarks. Hence, this chimeric peptide constitutes the first example of a virus-derived mitochondriotoxic compound as a candidate to kill selectively tumor neo-endothelia.


Subject(s)
Endothelial Cells/physiology , Gene Products, vpr/pharmacokinetics , Integrin alphaVbeta3/metabolism , Mitochondria/metabolism , Peptides/pharmacokinetics , Amino Acid Sequence , Animals , Apoptosis , Cell Survival , Dose-Response Relationship, Drug , Endothelial Cells/metabolism , Gene Products, vpr/pharmacology , Humans , Lysosomes/metabolism , Mice , Mice, Inbred BALB C , Mitochondrial Membranes/metabolism , Molecular Sequence Data , Peptides/pharmacology , Permeability
3.
Apoptosis ; 10(6): 1243-59, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16215683

ABSTRACT

During development as well as in pathological situations, neurons that fail to find appropriate targets or neurotrophic factors undergo cell death. Using primary cortical neurons subjected to acute serum-deprivation (SD), we have examined caspases activation, mitochondrial dysfunction and cell death parameters. Among a panel of metabolic, signaling and caspases inhibitors only those able to interfere with caspase-2 like activity protect primary neurons against SD-induced cell death. In situ detection and subcellular fractionation demonstrate a very early activation of cytosolic caspase-2, which controls Bax cleavage, relocalization and mitochondrial membrane permeabilization (MMP). Both z-VDVAD-fmk and a siRNA specific for caspase-2 abolish Bax changes, mitochondrial membranes permeabilization, as well as cytochrome c release-dependent activation of caspase-9/caspase-3, nuclear alterations, phosphatidylserine exposure, neurites dismantling and neuronal death. Hence, caspase-2 is an early checkpoint for apoptosis initiation in primary neurons subjected to serum deprivation.


Subject(s)
Apoptosis , Caspase 2/metabolism , Neurons/cytology , Neurons/enzymology , Serum , Animals , Apoptosis/drug effects , Caspase 2/deficiency , Cell Survival/drug effects , Cells, Cultured , Cytochromes c/metabolism , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Humans , Mice , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/metabolism , Models, Biological , Neurons/drug effects , Peptides/pharmacology , Protein Transport/drug effects , RNA Interference , bcl-2-Associated X Protein/metabolism
4.
Apoptosis ; 9(2): 157-69, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15004513

ABSTRACT

We describe here a cytofluorometric technology for the characterization of decision, execution, and degradation steps of neuronal apoptosis. Multiparametric flow cytometry was developed and combined to detailed fluorescence microscopy observations to establish the chronology and hierarchy of death-related events: neuron morphological changes, mitochondrial transmembrane potential (DeltaPsi(m)) collapse, caspase-3 and -9 activation, phosphatidyl-serine exposure, nuclear dismantling and final plasma membrane permeabilization. Moreover, we developed a reliable real-time flow cytometric monitoring of DeltaPsi(m) and plasma membrane integrity in response to neurotoxic insults including MPTP treatment. Taking advantage of recently developed specific fluorescent probes and a third generation pan-caspase inhibitor, this integrated approach will be pertinent to study the cell biology of neuronal apoptosis and to characterize new neuro-toxic/protective molecules.


Subject(s)
Apoptosis/physiology , Cerebral Cortex/physiology , Flow Cytometry , Neurons/physiology , Animals , Cerebral Cortex/cytology , Membrane Potentials/physiology , Mice , Mitochondria/physiology
5.
Genomics ; 70(2): 232-40, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11112351

ABSTRACT

The 2'-5' oligoadenylate synthetases (OAS) represent a family of interferon (IFN)-induced proteins implicated in the antiviral action of IFN. When activated by double-stranded (ds) RNA, these proteins polymerize ATP into 2'-5' linked oligomers with the general formula pppA(2'p5'A)n, n greater than or = 1. Three forms of human OAS have been described corresponding to proteins of 40/46, 69/71, and 100 kDa. These isoforms are encoded by three distinct genes clustered on chromosome 12 and exhibit differential constitutive and IFN-inducible expression. Here we describe the structural and functional analysis of the gene encoding the large form of human OAS. This gene has 16 exons with exon/intron boundaries that are conserved among the different isoforms of the human OAS family, reflecting the evolutionary link among them. The promoter region of the p100 gene is composed of multiple features conferring direct inducibility not only by IFNs but also by TNF and all-trans retinoic acid. In contrast, the induction of the p100 promoter by dsRNA is indirect and requires IFN type I production.


Subject(s)
2',5'-Oligoadenylate Synthetase/genetics , Isoenzymes/genetics , Base Sequence , Chromosomes, Human, Pair 12 , DNA Primers , Humans , Molecular Sequence Data , Promoter Regions, Genetic
6.
J Virol ; 74(12): 5587-96, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10823866

ABSTRACT

Hepatitis C virus (HCV) of genotype 1 is the most resistant to interferon (IFN) therapy. Here, we have analyzed the response to IFN of the human cell line UHCV-11 engineered to inducibly express the entire HCV genotype 1a polyprotein. IFN-treated, induced UHCV cells were found to better support the growth of encephalomyocarditis virus (EMCV) than IFN-treated, uninduced cells. This showed that expression of the HCV proteins allowed the development of a partial resistance to the antiviral action of IFN. The nonstructural 5A (NS5A) protein of HCV has been reported to inhibit PKR, an IFN-induced kinase involved in the antiviral action of IFN, at the level of control of protein synthesis through the phosphorylation of the initiation factor eIF2alpha (M. Gale, Jr., C. M. Blakely, B. Kwieciszewski, S. L. Tan, M. Dossett, N. M. Tang, M. J. Korth, S. J. Polyak, D. R. Gretch, and M. G. Katze, Mol. Cell. Biol. 18:5208-5218, 1998). Accordingly, cell lines inducibly expressing NS5A were found to rescue EMCV growth (S. J. Polyak, D. M. Paschal, S. McArdle, M. J. Gale, Jr., D. Moradpour, and D. R. Gretch, Hepatology 29:1262-1271, 1999). In the present study we analyzed whether the resistance of UHCV-11 cells to IFN could also be attributed to inhibition of PKR. Confocal laser scanning microscopy showed no colocalization of PKR, which is diffuse throughout the cytoplasm, and the induced HCV proteins, which localize around the nucleus within the endoplasmic reticulum. The effect of expression of HCV proteins on PKR activity was assayed in a reporter assay and by direct analysis of the in vivo phosphorylation of eIF2alpha after treatment of cells with poly(I)-poly(C). We found that neither PKR activity nor eIF2alpha phosphorylation was affected by coexpression of the HCV proteins. In conclusion, expression of HCV proteins in their biological context interferes with the development of the antiviral action of IFN. Although the possibility that some inhibition of PKR (by either NS5A or another viral protein) occurs at a very localized level cannot be excluded, the resistance to IFN, resulting from the expression of the HCV proteins, cannot be explained solely by inhibition of the negative control of translation by PKR.


Subject(s)
Antiviral Agents/antagonists & inhibitors , Hepacivirus/metabolism , Interferons/antagonists & inhibitors , Viral Proteins/biosynthesis , eIF-2 Kinase/metabolism , 2',5'-Oligoadenylate Synthetase/biosynthesis , 2',5'-Oligoadenylate Synthetase/metabolism , Antiviral Agents/pharmacology , Cytoplasm/chemistry , Cytoplasm/enzymology , Encephalomyocarditis virus/drug effects , Encephalomyocarditis virus/physiology , Endoplasmic Reticulum/chemistry , Eukaryotic Initiation Factor-2/metabolism , Gene Expression/drug effects , Gene Expression Regulation, Viral/drug effects , Hepacivirus/drug effects , Hepacivirus/genetics , Humans , Interferons/pharmacology , Microscopy, Confocal , Phosphorylation/drug effects , Poly I-C/pharmacology , Polyproteins/biosynthesis , Polyproteins/genetics , Polyproteins/metabolism , Protein Biosynthesis/drug effects , Tetracycline/pharmacology , Tumor Cells, Cultured , Viral Nonstructural Proteins/biosynthesis , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism , Viral Proteins/genetics , Viral Proteins/metabolism , eIF-2 Kinase/antagonists & inhibitors , eIF-2 Kinase/biosynthesis
7.
J Interferon Cytokine Res ; 19(4): 295-308, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10334380

ABSTRACT

2',5'-Oligoadenylate synthetase (2',5'-OAS) was discovered and characterized as an interferon (IFN)-induced enzyme that in the presence of double-stranded (ds) RNA converts ATP into 2',5'-linked oligomers of adenosine with the general formula pppA(2'p'A)n, n > or = 1. The product is pppG2'p5'G when GTP is used as a substrate. Now, 20 years later, this activity is attributed to several well-characterized, homologous, and IFN-induced proteins in human cells. Three distinct forms of 2',5'-OAS exist, small, medium, and large, which contain 1, 2, and 3 OAS units, respectively, and are encoded by distinct genes clustered on the 2',5'-OAS locus on human chromosome 12. Recently, other IFN-induced proteins homologous to the OAS unit but devoid of the typical 2',5'-OAS catalytic activity have been described. These OAS-related proteins are encoded by a gene located at the proximity of the 2',5'-OAS locus. These findings illustrate the apparent structural and functional complexity of the human 2',5'-OAS family.


Subject(s)
2',5'-Oligoadenylate Synthetase/metabolism , Interferons/pharmacology , Isoenzymes/metabolism , Multigene Family , RNA, Double-Stranded/genetics , 2',5'-Oligoadenylate Synthetase/genetics , Amino Acid Sequence , Animals , Conserved Sequence , Enzyme Induction , Humans , Isoenzymes/genetics , Molecular Sequence Data
8.
Eur J Biochem ; 262(1): 155-65, 1999 May.
Article in English | MEDLINE | ID: mdl-10231377

ABSTRACT

The 2',5' oligoadenylate synthetase (OAS) represents a family of interferon-induced proteins which, when activated by double-stranded (ds) RNA, polymerizes ATP into 2',5'-linked oligomers with the general formula pppA(2'p5'A)n, where n >/= 1. The 69-kDa form of human OAS has two isoforms (p69 and p71) that are identical for their first 683 amino acids and consist of two homologous and adjacent domains, each homologous to the small 40-kDa OAS. Here, we demonstrate that mRNA species specific for the isoforms p69 and p71 are enhanced in interferon-treated cells, with the p69 mRNA being more abundant than that of p71. In transfected cells, both isoforms could be expressed independently to generate enzymes with similar catalytic activity, typical of the natural 69-kDa OAS from interferon-treated cells. On the other hand, deletion mutants expressing either the N- or C-terminal domain common in p69 and p71 were greatly unstable and were found to be devoid of catalytic activity, in spite of the capacity of the C-terminal domain to bind dsRNA. Finally, we show that murine cell lines stably expressing either p69 or p71 isoforms partially resist infection by the encephalomyocarditis virus. These results indicate that both isoforms of the 69-kDa form of 2',5' OAS are expressed in interferon-treated cells, and that each isoform could be implicated in the mechanism of the anti-viral action of interferon.


Subject(s)
2',5'-Oligoadenylate Synthetase/metabolism , Antiviral Agents/metabolism , 2',5'-Oligoadenylate Synthetase/chemistry , 2',5'-Oligoadenylate Synthetase/genetics , Animals , Antiviral Agents/chemistry , Catalysis , Cell Line , Clone Cells , Humans , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Structure-Activity Relationship , Transfection
10.
J Biol Chem ; 274(3): 1557-65, 1999 Jan 15.
Article in English | MEDLINE | ID: mdl-9880533

ABSTRACT

The 2-5A synthetases represent a family of proteins implicated in the mechanism of the antiviral action of interferon. When activated by double-stranded RNA, these proteins polymerize ATP into 2'-5'-linked oligomers with the general formula pppA(2'p5'A)n, n >/= 1. Three forms of human 2-5A synthetases have been described corresponding to proteins of 40/46 (p40/p46), 69/71 (p69/p71), and 100 kDa (p100). Here we describe the molecular cloning and characterization of p100. By screening a cDNA expression library with a specific p100 polyclonal antibody, we first isolated a 590-nucleotide cDNA fragment which was subsequently used to isolate the full-length 6365-nucleotide cDNA. This cDNA recognizes a distinct interferon-induced messenger RNA of 7 kilobases. It has an open reading frame encoding a protein of 1087 amino acids including the sequence of seven peptides obtained by microsequencing of the natural p100 protein, which was purified from interferon-treated human cells. p100 is composed of three adjacent domains, each homologous to the previously defined catalytic unit of 350 amino acids, which is present as one unit in p40/p46 and as two units in p69/p71. The recombinant p100 synthesized preferentially dimeric 2', 5'-oligoadenylate molecules and displayed parameters for maximum enzyme activity similar to the natural p100. These results confirm that the enzymatic activity of p100 is distinct compared with that of p40/p46 and p69/p71.


Subject(s)
2',5'-Oligoadenylate Synthetase/metabolism , Adenine Nucleotides/biosynthesis , Oligoribonucleotides/biosynthesis , 2',5'-Oligoadenylate Synthetase/chemistry , 2',5'-Oligoadenylate Synthetase/genetics , Blotting, Northern , Catalysis , DNA, Complementary/chemistry , Dimerization , Fluorescent Dyes , HeLa Cells , Humans , Hydrogen-Ion Concentration , Interferon-alpha/pharmacology , Molecular Sequence Data , Molecular Weight , Open Reading Frames , RNA, Double-Stranded/metabolism , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Transfection
11.
Apoptosis ; 4(3): 169-78, 1999 Jun.
Article in English | MEDLINE | ID: mdl-14634279

ABSTRACT

DNA fragmentation is a key feature of the degradation phase of apoptosis. In this work we have developed an assay, based on radioimager (beta-IMAGER and micro-IMAGER) quantification of radioactive nick end labelling (RANEL), which is quantitative, rapid and sensitive to study in vitro and in vivo induced apoptosis. To establish the technique, in vitro apoptosis of T cell lines was induced by stimulation of the Fas receptor; cells were labelled using TdT-mediated [alpha-33P] dCTP nick end labelling, after which then radioactivity was quantified using a beta-IMAGER. We have also shown that the RANEL method can be applied to the quantification and visualisation, by micro-IMAGER analysis, of liver tissue sections from mouse Fas-induced fulminant hepatitis or from Dengue-1 virus infected individuals. Finally, this system has also been used to detect apoptosis induced by rabies virus in Jurkat T cells. These data have established a large field of application for the RANEL assay.

12.
Eur J Biochem ; 257(2): 319-30, 1998 Oct 15.
Article in English | MEDLINE | ID: mdl-9826176

ABSTRACT

The 2'-5' oligoadenylate synthetase (OAS) represents a family of interferon-induced proteins which when activated by double-stranded (ds) RNA polymerizes ATP into 2'-5' linked oligomers with the general formula pppA(2'p5'A)n, n> or =1. Three forms of human OASs have been described corresponding to proteins of 40/46, 69/71 and 100 kDa (p40/p46, p69/p71 and p100). Polyclonal antibodies raised against p100 cross reacted with the other forms p40/p46, p69/p71 but also with an interferon-induced 56-kDa protein (p56). By screening a cDNA expression library, these polyclonal antibodies selected a cDNA encoding p56. Further studies by the RACE procedure using primers corresponding to this cDNA, a p56-related protein of 30 kDa (p30) was isolated. Both p56 and p30 mRNA are expressed in interferon-treated cells as transcripts of 2 kb and 1.8 kb, respectively. The 1.8-kb mRNA is homologous to the 2-kb mRNA but with a 243-nucleotide deletion at position 1011, which results in a frameshift. Consequently, the p56 and p30 have their first 219 amino acid residues identical but differ at their C-termini. In vitro transcription-translation of p56 and p30 cDNAs generated proteins of 56 and 30 kDa, respectively. The deduced amino acid sequence of p56 kDa shares strong similarity with the previously cloned OASs, and contains the subdomains conserved in p40/p46 and p69/p71 forms. Transient expression in HeLa cells indicated that p30 has a cytoplasmic localization, whereas p56 has cytoplasmic and nucleolar localizations. The p56 isolated from transfected cells was shown to bind dsRNA and DNA, but it was devoid of 2'-5'OAS activity typical of the three known forms of this enzyme. Thus, p56 and p30 are two related and interferon-induced proteins outside the family of 2'-5'OAS, which might have as yet unidentified catalytic activities or functions.


Subject(s)
2',5'-Oligoadenylate Synthetase/genetics , Interferons/physiology , 2',5'-Oligoadenylate Synthetase/immunology , 2',5'-Oligoadenylate Synthetase/metabolism , Amino Acid Sequence , Antibodies/immunology , Base Sequence , Cell Line , Cloning, Molecular , Cross Reactions , DNA, Complementary , Humans , Molecular Sequence Data , Protein Binding , RNA, Double-Stranded/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Sequence Homology, Amino Acid , Transfection
13.
Genomics ; 52(3): 267-77, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9790745

ABSTRACT

The 2',5'-oligoadenylate synthetases (OAS) represent a family of interferon-induced proteins implicated in the mechanism of the antiviral action of interferon. When activated by double-stranded RNA, these proteins polymerize ATP into 2'-5'-linked oligomers with the general formula pppA(2'p5'A)n, n >/= 1. Three forms of human OAS corresponding to proteins of 40/46, 69/71, and 100 kDa have been described. Based on the deduced amino acid sequences of the corresponding cDNAs, these OAS share a homologous region of about 350 amino acid residues that could represent the functional domain of OAS; the 40/46 proteins contain one single domain, whereas the 69/71- and the 100-kDa proteins contain two and three adjacent domains, respectively. Here we show that the cDNAs for OAS-40/46, OAS-69/71, and OAS-100 hybridize to distinct interferon-induced mRNAs of 2 kb; 2.8, 3.3, 3.9, and 4.5 kb; and 7 kb, respectively. By in situ hybridization, we assign the human OAS-40/46, OAS-69/71, and OAS-100 genes (referred to as OAS1, OAS2, and OAS3, respectively) to a unique cytogenetic location on chromosomal region 12q24.2. We constructed a YAC, PAC, and cosmid contig carrying the three OAS genes and provide evidence that the three genes are clustered within a single PAC clone of 130 kb. The three OAS genes are flanked by markers WI-10614 (cen) and D12S2293 (tel) and are contained within three sets of overlapping cosmid clones. They share the same orientation of transcription and are arranged in the order cen- 5'-OAS1-OAS3-OAS2-3'-tel. We suggest that clustering of these genes reflects their evolutionary relationship possibly through the duplication of the conserved functional domain. This ready-to-sequence PAC and cosmid contig provides a valuable tool for identifying regulatory elements involved in the transcription of the OAS genes when induced by interferon and for elucidating the exon-intron organization of these genes.


Subject(s)
2',5'-Oligoadenylate Synthetase/genetics , Chromosomes, Human, Pair 12/genetics , Chromosome Mapping , Cloning, Molecular , Genetic Markers/genetics , Humans , In Situ Hybridization, Fluorescence , Polymerase Chain Reaction , RNA, Messenger/genetics , Sequence Analysis, DNA
14.
Exp Cell Res ; 239(2): 379-92, 1998 Mar 15.
Article in English | MEDLINE | ID: mdl-9521856

ABSTRACT

The protein kinase PKR and the 2',5'-oligoadenylate (2-5A) synthetase are two interferon-induced and double-stranded RNA-activated enzymes which are implicated in the mechanism of action of interferon. Their distribution was undertaken here at the ultrastructural level by the immunogold procedure, following the use of specific monoclonal antibodies directed against PKR and 69- and 100-kDa forms of the 2-5A synthetase. These enzymes were detected as a pool of nonaggregated proteins scattered throughout the cell and as aggregates often associated with electron-dense doughnut-like structures showing a similar aspect whatever their subcellular localization: the cytoplasm, the nuclear envelope, and the nucleus. In general, the 2-5A synthetases were present in much more lower amounts than the PKR, probably due to the difficulty of detecting traces of proteins by electron microscopy. To circumvent this, we used a human lymphoblastoid cell line overexpressing the 69-kDa form of the 2-5A synthetase. In such cells, the synthetase was then clearly observed in both the cytoplasm and the nucleus; isolated or small clusters of gold particles were numerous in the cell mainly over the RNP fibrils of the interchromatin space, nucleolus, and ribosomes. Interestingly, gold particles were also found to be associated with the membranes of nuclear envelope and rough endoplasmic reticulum probably due to the myristilated motif of this form of 2-5A synthetase. Finally, intensely labeled electron-opaque dots sometimes associated with the nuclear pore complexes were present in the nucleus and in the cytoplasm of cells which might suggest their transport from the nucleus to the cytoplasm or reciprocally through the nuclear pore complexes. These observations indicate the wider distribution of the dsRNA-activated enzymes in the cell, thus pointing out their potential implication in as yet undetermined physiological function(s) necessary for various cellular metabolic reactions.


Subject(s)
2',5'-Oligoadenylate Synthetase/analysis , Interferon Type I/pharmacology , RNA, Double-Stranded/metabolism , eIF-2 Kinase/analysis , 2',5'-Oligoadenylate Synthetase/genetics , 2',5'-Oligoadenylate Synthetase/immunology , 2',5'-Oligoadenylate Synthetase/physiology , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Cell Compartmentation , Cell Line , Cell Nucleus/enzymology , Cytoplasm/enzymology , Enzyme Activation , Enzyme Induction/drug effects , Epitopes/immunology , Humans , Immunohistochemistry , Mice , Neoplasm Proteins/analysis , Neoplasm Proteins/physiology , Nuclear Envelope/metabolism , Recombinant Proteins , Subcellular Fractions/enzymology , T-Lymphocytes , Transfection , eIF-2 Kinase/immunology , eIF-2 Kinase/physiology
15.
Eur J Biochem ; 248(2): 558-66, 1997 Sep 01.
Article in English | MEDLINE | ID: mdl-9346316

ABSTRACT

The (2'-5')oligoadenylate synthetase represents a family of interferon-induced proteins which when activated by double-stranded (ds)RNA polymerizes ATP into 2'-5'-linked oligomers with the general formula pppA(2'p5'A)n, where n > 1, which for convenience are referred to as 2-5A. We studied here the influence of pH, dsRNA concentration and time on oligomeric composition of 2-5A synthesized by purified 69-kDa and 100-kDa isoforms of (2'-5')oligo(adenylate) synthetase. In optimal conditions for activity, the 69-kDa form synthesized higher oligomers of 2-5A molecules whereas the 100 kDa form synthesized preferentially dimeric molecules, which are known not to be functional for the activation of RNase L. This difference does not reflect a differential affinity of the enzymes for the preformed 2-5A dimer, which is found to be a very poor substrate for both enzymes. This latter strongly suggests that the mechanism of elongation is more likely processive. Moreover, we show that both isoforms have efficient nucleotidyl-transferase activity and provide evidence that, in optimized conditions, GTP can be used alone as substrate by these enzymes to generate pppG2'p5'G. Our results clearly demonstrate that the 69-kDa and 100-kDa forms of (2'-5')oligoadenylate synthetase manifest various differential catalytic activities, and favor the hypothesis that these enzymes might have other functions in the cell besides those in the 2-5A system.


Subject(s)
2',5'-Oligoadenylate Synthetase/metabolism , Interferons/pharmacology , 2',5'-Oligoadenylate Synthetase/drug effects , Guanosine Triphosphate/metabolism , Humans , Isoenzymes/metabolism , Kinetics , Substrate Specificity
16.
J Interferon Res ; 12(5): 377-87, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1431317

ABSTRACT

Multiple copy tandem repeats polymers of an authentic 30-bp region of the human interferon-beta (IFN-beta) promoter between positions-91 to -62 relative to the cap site or the hexanucleotide GAAAGT derived from this region, both acted as strong constitutive regulatory elements in transfected HeLa cells. Such polymers were unresponsive to treatment with IFN-alpha despite their considerable homology with the IFN-responsive elements of other genes but were highly responsive to treatment of HeLa cells with IFN-gamma. Virus induction of HeLa cells transfected with polymers of the 30-bp region linked to a CAT gene increased the activity of the reporter gene 500- to 2,000-fold over baseline levels. Treatment with IFN-alpha prior to virus induction did not increase further CAT activity. Cotransfection of HeLa cells with the CAT gene under the control of a 12-element tandem repeat polymer of the human IFN-beta promoter and an expression vector for the IRF-1 transcriptional activator markedly increased CAT activity while cotransfection of HeLa cells with the IFN-beta construct together with an expression vector for the transcriptional regulator IRF-2 markedly decreased CAT activity relative to cells transfected with the IFN-beta polymer alone.


Subject(s)
Interferon-beta/genetics , Promoter Regions, Genetic/drug effects , Transcription Factors/pharmacology , Transfection/genetics , Base Sequence , Biopolymers , Chloramphenicol O-Acetyltransferase/genetics , Gene Expression Regulation, Neoplastic/genetics , HeLa Cells , Humans , Molecular Sequence Data , Plasmids/genetics , Repetitive Sequences, Nucleic Acid/genetics , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...